Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 10
Submit an article Journal homepage
75
Views
12
CrossRef citations to date
0
Altmetric
Review

Phosphodiesterase-5 inhibitors in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia

Konstantinos Giannitsas Medical School University of Patras, Patras 26500, Greece +30 2610 999385; +30 2610 993981; [email protected]
,
Dionisios Mitropoulos Medical School University of Athens, Athens, Greece
,
Angelis Konstantinopoulos Medical School University of Patras, Patras 26500, Greece +30 2610 999385; +30 2610 993981; [email protected]
,
Anastasios Athanasopoulos Medical School University of Patras, Patras 26500, Greece +30 2610 999385; +30 2610 993981; [email protected]
&
Petros Perimenis Medical School University of Patras, Patras 26500, Greece +30 2610 999385; +30 2610 993981; [email protected]
Pages 1687-1693 | Published online: 21 Jun 2008

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Woo Jin Ko, Hyun Ho Han, Won Sik Ham & Hae Won Lee. (2017) Daily use of sildenafil 50mg at night effectively ameliorates nocturia in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: an exploratory multicenter, double-blind, randomized, placebo-controlled study. The Aging Male 20:2, pages 81-88.
Read now
Konstantinos Giannitsas, Angelis Konstantinopoulos, Christos Patsialas, Anastasios Athanasopoulos & Petros Perimenis. (2009) Preclinical compounds for the treatment of overactive bladder. Expert Opinion on Therapeutic Patents 19:2, pages 107-117.
Read now

Articles from other publishers (10)

Julia Franz, Kristin Kieselbach, Claas Lahmann, Christian Gratzke & Arkadiusz Miernik. (2023) Chronic primary pelvic pain syndrome in men—differential diagnostic evaluation and treatment. Deutsches Ärzteblatt international.
Crossref
Vanessa N. Pena, Noah Engel, Andrew T. Gabrielson, Matthew J. Rabinowitz & Amin S. Herati. (2021) Diagnostic and Management Strategies for Patients with Chronic Prostatitis and Chronic Pelvic Pain Syndrome. Drugs & Aging 38:10, pages 845-886.
Crossref
Antonio La Torre, Caterina Palleria, Irene Tamanini, Andrea Scardigli, Tommaso Cai, Manuela Colosimo, Lucia Muraca, Vincenzo Rania, Davida Mirra, Alessandro Casarella, Gianmarco Marcianò, Giovambattista De Sarro & Luca Gallelli. (2021) Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors. Uro 1:3, pages 82-98.
Crossref
Y S Shim, C-U Pae, K J Cho, S W Kim, J C Kim & J S Koh. (2013) Effects of daily low-dose treatment with phosphodiesterase type 5 inhibitor on cognition, depression, somatization and erectile function in patients with erectile dysfunction: a double-blind, placebo-controlled study. International Journal of Impotence Research 26:2, pages 76-80.
Crossref
Do Hoon KongChang Jin YunHyun Jun ParkNam Cheol Park. (2014) The Efficacy of Mirodenafil for Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Middle-Aged Males. The World Journal of Men's Health 32:3, pages 145.
Crossref
Joo Yong Lee, Sung Yul Park, Tae Yoong Jeong, Hong Sang Moon, Yong Tae Kim, Tag Keun Yoo, Hong Yong Choi, Hae Young Park & Seung Wook Lee. (2013) Combined Tadalafil and α‐Blocker Therapy for Benign Prostatic Hyperplasia in Patients With Erectile Dysfunction: A Multicenter, Prospective Study. Journal of Andrology 33:3, pages 397-403.
Crossref
Anthony Kanai, Irina Zabbarova, Michael Oefelein, Piotr Radziszewski, Youko Ikeda & Karl‐Erik Andersson. (2012) Mechanisms of action of botulinum neurotoxins, β 3 ‐adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI‐RS 2011 . Neurourology and Urodynamics 31:3, pages 300-308.
Crossref
J Y Lee, S Y Cho, C Y Oh, U S Ha, S H Lee, S Y Park, H S Moon & S W Lee. (2011) Efficacy and safety of combination therapy with mirodenafil and α1-blocker for benign prostatic hyperplasia-induced lower urinary tract symptoms accompanied by erectile dysfunction: a multicenter, open-label, prospective study. International Journal of Impotence Research 23:6, pages 249-256.
Crossref
Y S Shim, C-U Pae, S W Kim, H W Kim, J C Kim & J S Koh. (2011) Effects of repeated dosing with Udenafil (Zydena) on cognition, somatization and erection in patients with erectile dysfunction: a pilot study. International Journal of Impotence Research 23:3, pages 109-114.
Crossref
David RP Guay. (2009) Silodosin: an orally active selective α 1 -adrenoceptor antagonist for benign prostatic hyperplasia . Aging Health 5:4, pages 459-473.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.